Conversely, the group with lower MET exhibited a mere 50.9% PFS rate over six months [147]
Over 52 weeks, resolution of MASH without worsening of fibrosis was achieved in 10% of the placebo group, 44% of the tirzepatide 5 mg group, 56% of the 10 mg group, and 62% of the 15 mg group
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
8.1 Next-generation probiotics and recombinant forms of GLP-1 The concept of genetically modified probiotics is based on the creation of bacterial strains with predefined therapeutic functions that can synthesize biologically active molecules, such as hormones, cytokines, or peptides, directly within the gut
It supports a variety of use cases, from brainstorming sessions to complex project management